Symmetry Investments’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
6,818
+4,960
+267% +$1.86M 0.17% 71
2026
Q1
$523K Buy
+1,858
New +$539K 0.06% 105
2025
Q3
Sell
-12,400
Closed -$1.94M 150
2025
Q2
$1.94M Sell
12,400
-18,300
-60% -$1.95M 0.13% 77
2025
Q1
$2.42M Sell
30,700
-10,000
-25% -$1.06M 0.17% 88
2024
Q4
$3.76M Buy
+40,700
New +$3.18M 0.2% 69
2023
Q4
Sell
-51,200
Closed -$1.26M 207
2023
Q3
$1.26M Buy
+51,200
New +$1.05M 0.26% 85

Other funds holding CLS

Symmetry Investments's CLS Position: Q2 2026 in Review

Symmetry Investments increased its Celestica (CLS) stake by 267% in Q2 2026, buying an estimated $1.86M and bringing the position to 6,818 shares worth $2.49M. The position accounts for 0.17% of the portfolio, ranked #71.

Symmetry Investments first reported a position in CLS in Q3 2023 and has held it in 6 quarters since. The position peaked at $3.76M in Q4 2024. 873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Symmetry Investments held 6,818 shares of Celestica worth $2.49M as of Q2 2026.
  • Symmetry Investments bought 4,960 Celestica shares in Q2 2026, an estimated $1.86M.
  • Celestica made up 0.17% of Symmetry Investments's portfolio in Q2 2026, its #71 holding.
  • Symmetry Investments first reported a position in Celestica in Q3 2023 and has held it in 6 quarters since.
  • Symmetry Investments's Celestica position peaked at $3.76M in Q4 2024.
  • 873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Symmetry Investments's 13F filing for Q2 2026, filed 14 Aug 2026.